Article: ALZA Acquires Flexeril(R) Product and Trademark in United States and Canada.

MOUNTAIN VIEW, Calif., Feb. 5 /PRNewswire/ --

ALZA Corporation (NYSE: AZA) today announced that it has acquired certain marketing rights to the Flexeril(R) (cyclobenzaprine) product and trademark from Merck and Co., Inc. (NYSE: MRK). ALZA is currently developing a novel once-a-day OROS(R) formulation of cyclobenzaprine.

(Photo: NewsCom: http://www.newscom.com/cgi-bin/prnh/19991124/ALZALOGO )

Under the terms of the agreement, ALZA will obtain exclusive sales and marketing rights for Flexeril(R) and the exclusive license to the Flexeril(R) trademark for pharmaceutical sales, in the United States and Canada, in each case excluding ...

Related newspaper, magazine, and journal articles:

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!